olanzapine pamoate LAI
Selected indexed studies
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. (Am J Psychiatry, 2020) [PMID:31838873]
- Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. (CNS Drugs, 2021) [PMID:33507525]
- Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis. (Eur Neuropsychopharmacol, 2024) [PMID:38490016]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. (2020) pubmed
- Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. (2021) pubmed
- Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches. (2023) pubmed
- Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis. (2024) pubmed
- Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder. (2024) pubmed
- Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. (2024) pubmed
- Long-Acting Injectable Second-Generation Antipsychotics vs Placebo and Their Oral Formulations in Acute Schizophrenia: A Systematic Review and Meta-Analysis of Randomized-Controlled-Trials. (2024) pubmed
- Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis. (2024) pubmed
- Olanzapine pamoate for the treatment of schizophrenia--a safety evaluation. (2016) pubmed
- Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis. (2023) pubmed